HomeInsightsEPS

Emcure Pharmaceuticals Ltd EPS

Emcure Pharmaceuticals Ltd EPS

stocks purchased

₹ 0.4 Cr

Volume Transacted

(Jan 15, 2025)

stocks purchased

3.3 K

Stocks Traded

(Jan 15, 2025)

Last Updated on: Jan 15, 2025

Image

Emcure Pharmaceuticals Ltd

NSE: EMCURE

EPS

₹ 30.3

Last updated on: Jan 14, 2025

Key Highlights

  • The Earning per Share of Emcure Pharmaceuticals Ltd is ₹ 30.3 as of 14 Jan 25 .
  • The earning per share of Emcure Pharmaceuticals Ltd changed from ₹ 7.21 to ₹ 10.23 over 6 quarters. This represents a CAGR of 26.27% .

Historical Earning per Share of Emcure Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Emcure Pharmaceuticals Ltd

Market Cap

25,600 Cr

EPS

30.3

P/E Ratio (TTM) *

44.6

P/B Ratio (TTM) *

6.2

Day’s High *

1384.05

Day’s Low

1340.5

DTE *

0.3

ROE *

13.8

52 Week High

1577.5

52 Week Low

1226.5

ROCE *

18.7

Market Price of Emcure Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Emcure Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 20251351.45
13 Jan 20251315.7
10 Jan 20251355.35
09 Jan 20251433.1
08 Jan 20251450.05
07 Jan 20251418.15
06 Jan 20251425.3
03 Jan 20251463.45
02 Jan 20251478.35
01 Jan 20251461.4

BlinkX Score for Emcure Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Emcure Pharmaceuticals Ltd

Market Value

25,601

Asset Value

4,171

5.1 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Emcure Pharmaceuticals Ltd3025,600
Sun Pharmaceuticals Industries Ltd464,24,382
Divis Laboratories Ltd691,59,224
Cipla Ltd571,16,943
Dr Reddys Laboratories Ltd631,11,588
Mankind Pharma Ltd511,10,215

Historical Market Cap of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Emcure Pharmaceuticals Ltd News Hub

News

Emcure Pharmaceuticals announces resignation of senior management personnel

Emcure Pharmaceuticals announced that Aravamuthan Balaji, President - IT & Digital and Sen...

Read more

29 Nov 2024 19:25

News

Emcure Pharmaceuticals allots 3.33 lakh equity shares under ESOS

Emcure Pharmaceuticals has allotted 3,33,500 equity shares under ESOS on 22 November 2024....

Read more

22 Nov 2024 17:56

News

Emcure Pharma Q2 PAT rises 38.2% YoY

In Q2FY25, the drug maker's consolidated revenue from operations stood at Rs 2,002 crore, ...

Read more

08 Nov 2024 12:50

News

Emcure Pharmaceuticals to hold board meeting

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 N...

Read more

02 Nov 2024 13:58

News

Emcure Pharmaceuticals to announce Quarterly Result

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 N...

Read more

31 Oct 2024 10:43

News

Emcure signs licensing agreement with Gilead Sciences

Emcure Pharmaceuticals announced the signing of a royalty-free voluntary licensing agreeme...

Read more

03 Oct 2024 10:15

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Emcure Pharmaceuticals Ltd

What is the EPS of Emcure Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Emcure Pharmaceuticals Ltd is 30.3. An EPS is the amount of net income attributed to each share of a common stock.

How is Emcure Pharmaceuticals Ltd EPS calculated?

The EPS of Emcure Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Emcure Pharmaceuticals Ltd report its EPS?

Emcure Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Emcure Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Emcure Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Emcure Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Emcure Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions